Compass Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Supports Biotechs Pipeline Progress PRTS Q1 2026 Earnings EPS Surprises with 4885 Beat Stock Falls 392 PFLT Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Falls Short CIG Q1 2026 Earnings EPS Beat Fails to Ignite Stock as Revenue Details Remain Absent Tactile Systems Technology Q1 2026 Earnings NarrowerThanExpected Loss Masks Lack of Revenue Details SKWD Q1 2026 Earnings EPS Surges Past Estimates Despite Limited Revenue Disclosure